Correction: Bendamustine (Treanda) for CLL and NHL

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1300

December 1, 2008

View Complete Issue Table of Contents 2019

Correction: Bendamustine (Treanda) for CLL and NHL

Download PDF: US English

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2008 Dec 1;50(1300):96

Disclosures

Objective(s)

Select a term to see related articles 2008 Bendamustine Bendamustine (Treanda) for CLL and NHL carbamazepine chronic lymphocytic leukemia Cipro Ciprofloxacin CLL Clorambucil correction cyclophosphamide December 1 Fludara fludarabine fluvoxamine Issue 1299 Issue 1300 Leukeran Luvox NHL Non-Hodgkin's lymphoma November 17 page 91 page 96 Rituxan rituximab Tegretol Tobacco Treanda volume 50

(Med Lett Drugs Ther 2008; 50:91) In the Clinical Studies section, the complete response rate with chlorambucil for CLL was 2% (not 24%).

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.